| Record ID | ia:assessingeconomi0148neym |
| Source | Internet Archive |
| Download MARC XML | https://archive.org/download/assessingeconomi0148neym/assessingeconomi0148neym_marc.xml |
| Download MARC binary | https://www.archive.org/download/assessingeconomi0148neym/assessingeconomi0148neym_meta.mrc |
LEADER: 03777cam 2200985 a 4500
001 ocm38180353
003 OCoLC
005 20200423043145.0
008 971230s1998 gw b 001 0 eng
010 $a 97052408
040 $aDNLM/DLC$beng$cDLC$dYDX$dNLM$dEUN$dOHX$dUKM$dBAKER$dNLGGC$dBTCTA$dYDXCP$dHEBIS$dZWZ$dOCLCQ$dBDX$dOCLCF$dOCLCQ$dOCLCO$dDEBBG$dOCLCQ$dUKMGB
015 $aGB9848510$2bnb
016 7 $a952463156$2DE-101
016 7 $a9801220$2DNLM
016 7 $a006423729$2Uk
016 7 $a006442408$2Uk
019 $a39442750
020 $a3540640304$q(hardcover ;$qalk. paper)
020 $a9783540640301$q(hardcover ;$qalk. paper)
035 $a(OCoLC)38180353$z(OCoLC)39442750
050 00 $aRC261$b.R35 vol. 148
060 00 $aW1$bRE106P v.148 1998
060 10 $aQZ 266$bN572a 1998
072 7 $aRA$2lcco
082 00 $a616.99/4 s$a338.4/361699406$221
084 $a44.81$2bcl
084 $aXH 3103$2rvk
084 $aXH 3900$2rvk
100 1 $aNeymark, Niels.
245 10 $aAssessing the economic value of anticancer therapies /$cN. Neymark.
246 3 $aAssessing the economic value of anti-cancer therapies
260 $aBerlin ;$aNew York :$bSpringer,$c℗♭1998.
300 $axi, 285 pages ;$c25 cm.
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
338 $avolume$bnc$2rdacarrier
490 1 $aRecent results in cancer research,$x0080-0015 ;$v148
504 $aIncludes bibliographical references (pages 277-285).
650 0 $aCancer$xTreatment$xEconomic aspects.
650 0 $aCancer$xTreatment$xCost effectiveness.
650 0 $aMedical care, Cost of.
650 12 $aNeoplasms$xtherapy.
650 22 $aCost-Benefit Analysis$xmethods.
650 22 $aHealth Care Costs.
650 22 $aNeoplasms$xeconomics.
650 7 $aTumeurs$xThe rapeutique.$2fmesh
650 7 $aTumeurs$xE conomie.$2fmesh
650 7 $aCou t soins me dicaux.$2fmesh
650 7 $aAnalyse cou t-be ne fice$xMe thodes.$2fmesh
650 7 $aCancer$xTreatment$xCost effectiveness.$2fast$0(OCoLC)fst00845542
650 7 $aCancer$xTreatment$xEconomic aspects.$2fast$0(OCoLC)fst00845544
650 7 $aMedical care, Cost of.$2fast$0(OCoLC)fst01013902
650 17 $aKanker.$2gtt
650 17 $aTherapiee n.$2gtt
650 17 $aEconomische waarde.$2gtt
650 07 $aKosten-Nutzen-Analyse.$0(DE-588)4032589-1$2gnd
650 07 $aKrebs (Medizin)$0(DE-588)4073781-0$2gnd
650 07 $aTherapie.$0(DE-588)4059798-2$2gnd
650 7 $aCancer$xThe rapeutique$xAspect e conomique.$2ram
650 7 $aSoins me dicaux$xCou t.$2ram
650 07 $aKosten-Nutzen-Analyse.$2swd
650 07 $aKrebs <Medizin>$2swd
650 07 $aTherapie.$2swd
655 2 $aReview.
830 0 $aRecent results in cancer research ;$v148.$x0080-0015
856 41 $3Table of contents$uhttp://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=008110032&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA
856 $31850-9999$uhttp://www.springer.com/gb/$xBLDSS
938 $aBaker & Taylor$bBKTY$c109.00$d109.00$i3540640304$n0003114010$sactive
938 $aBrodart$bBROD$n52361608$c$109.00
938 $aBaker and Taylor$bBTCP$n97052408
938 $aOtto Harrassowitz$bHARR$nhar005041484
938 $aYBP Library Services$bYANK$n1496822
029 1 $aAU@$b000013662226
029 1 $aDEBBG$bBV011984788
029 1 $aGEBAY$b5803141
029 1 $aHEBIS$b058451854
029 1 $aNLGGC$b166091103
029 1 $aNLM$b9801220
029 1 $aNZ1$b4842565
029 1 $aOHX$bhar005041484
029 1 $aYDXCP$b1496822
029 1 $aUKMGB$b006423729
029 1 $aUKMGB$b006442408
994 $aZ0$bP4A
948 $hHELD BY P4A - 131 OTHER HOLDINGS